[Featured Stock] Medical Device Manufacturer Cellumed Shows Early Strong Rise... Up 24%
Cellumed, a specialized manufacturer of bio medical devices, is showing strong performance in the early trading session.
As of 9:07 AM on the 3rd, Cellumed is trading on the KOSDAQ market at 1,879 KRW, up 363 KRW (23.94%) from the previous trading day.
Cellumed was established in May 1985 as New Tech Man, and in March 2013, the company name was changed from Korea Bonbank Co., Ltd. to Cellumed Co., Ltd.
![[Featured Stock] Medical Device Manufacturer Cellumed Shows Early Strong Rise... Up 24%](http://www.asiae.co.kr/news/img_view.htm?img=2024072208164559128_1721603806.jpg)
The business divisions are classified into medical devices, biologics, and cosmeceuticals. In the medical device sector, they handle tissue engineering for demineralized bone and knee cartilage, artificial knee joints, and allogeneic heterografts.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
The mRNA vaccine production enzyme business is being developed in partnership with Germany through contract development, and the company is also pursuing secondary battery and electric two-wheeler businesses.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
